\ Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access
Company News: Page (1) of 1 - 09/13/17

Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access

Strategic Collaboration Aimed at Exclusive Test Development and Commercialization of Proprietary Genomic Health Tests on the Idylla™ Platform

September 13, 2017 --
This article is no longer available,but here are some related topics.

Page: 1
Related Keywords:USA, Inc.,Disease,healthcare,Cancer,Surgery,Womens Health,Science,Medical,Genetics,Cancer,Business,Other,

Source:PR Newswire. All Rights Reserved

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved

Webmaster
Privacy.